Interesting facts
Interesting Facts about Benzo[b][1]benzazepine-11-carboxamide
Benzo[b][1]benzazepine-11-carboxamide is a fascinating compound with a notable structure and potential applications. Here are some intriguing aspects of this compound:
- Structural Complexity: The compound's complex structure features a fused ring system, which is a characteristic of many biologically active molecules. This structural intricacy often correlates with interesting pharmacological properties.
- Biological Activity: Compounds with a benzazepine framework are frequently studied for their pharmacological effects. They may exhibit activity against various diseases by interacting with specific receptors in the body.
- Research Applications: In medicinal chemistry, benzo[b][1]benzazepine derivatives are being investigated for their potential as therapeutic agents, particularly in treating conditions such as anxiety, depression, and certain neurological disorders.
- Synthetic Routes: Chemists are continually developing new synthetic methods to create derivatives of this compound, enhancing its accessibility for research and potential medicinal use.
- Environmental Considerations: Understanding the environmental behavior of this compound is crucial, especially as researchers assess the safety and impact of new chemicals in ecological systems.
As the study of chemistry evolves, compounds like benzo[b][1]benzazepine-11-carboxamide are pivotal in expanding our knowledge of molecular interactions and drug design. “In every compound, there's a story waiting to be told,” says a renowned chemist, highlighting the excitement inherent in chemical research.
Synonyms
carbamazepine
298-46-4
Tegretol
Carbamazepen
Biston
Finlepsin
Equetro
Tegretal
5H-Dibenzo[b,f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
Carbazepine
Timonil
Carbamezepine
Karbamazepin
Carbatrol
Neurotol
Stazepine
Telesmin
Epitol
Carbamazepin
Lexin
Tegretol-Xr
Carbamazepina
Carbamazepinum
Teril
Geigy 32883
Amizepin
Bipotrol
Carnexiv
Sirtal
benzo[b][1]benzazepine-11-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
Calepsin
5-Carbamoyl-5H-dibenz(b,f)azepine
Karbelex
Neurotop
G-32883
Carbamazepine Anhydrous
5-Carbamoyl-5H-dibenz[b,f]azepine
G 32883
NSC 169864
MFCD00005073
CHEBI:3387
HSDB 3019
Carbatrol extended-release
Carbamazepinum [INN-Latin]
EINECS 206-062-7
Carbamazepina [INN-Spanish]
Carbamazepine extended release
5-Carbamyldibenzo(b,f)azepine
NSC-169864
BRN 1246090
5-Carbamoyldibenzo(b,f)azepine
DTXSID4022731
UNII-33CM23913M
NSC169864
CBZ
CHEMBL108
33CM23913M
MLS000069652
DTXCID902731
NCGC00015234-11
Carbamazepine [USAN:USP:INN:BAN:JAN]
CAS-298-46-4
SMR000058201
Stazepin
Carbamazepinum (INN-Latin)
Carbamazepina (INN-Spanish)
CARBAMAZEPINE (MART.)
CARBAMAZEPINE [MART.]
CARBAMAZEPINE (USP-RS)
CARBAMAZEPINE [USP-RS]
5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A
Carbelan
CARBAMAZEPINE (EP MONOGRAPH)
CARBAMAZEPINE (USP IMPURITY)
CARBAMAZEPINE [EP MONOGRAPH]
CARBAMAZEPINE [USP IMPURITY]
CARBAMAZEPINE (USP MONOGRAPH)
CARBAMAZEPINE [USP MONOGRAPH]
Tegretol Cr
5H-dibenzo(b,f)azepine-5-carboxamide
Carbamazepine (USAN:USP:INN:BAN:JAN)
SMR001227191
OXCARBAZEPINE IMPURITY A (EP IMPURITY)
OXCARBAZEPINE IMPURITY A [EP IMPURITY]
SR-01000000229
Carbmazepine
Trimonil
CarbamazepineER
Neurotop retard
Carbamazepine?
TegretolXR
Carbamazepine ER
dibenzo[b,f]azepine-5-carboxamide
Tegretol (TN)
N6W
Prestwick_104
Equetro (TN)
Carbamazepine, powder
Opera_ID_72
Spectrum_000096
5H-Dibenz[b,f]azepine-5-carboxamide;5-Carbamoyl-5H-dibenz[b,f]azepine;Amizepin
Carbamazepine (Standard)
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Carbamazepine (Carbatrol)
Lopac-C-4024
ChemDiv1_018966
CARBAMAZEPINE [MI]
CBChromo1_000350
Epitope ID:174842
Iminostilbene-N-carboxamide
CARBAMAZEPINE [INN]
CARBAMAZEPINE [JAN]
CARBAMAZEPINE [HSDB]
CARBAMAZEPINE [USAN]
Lopac0_000292
Oprea1_790775
SCHEMBL21639
BSPBio_000203
BSPBio_001929
CARBAMAZEPINE [VANDF]
KBioGR_000724
KBioSS_000516
MLS001055475
MLS001074172
MLS002548877
BIDD:GT0479
DivK1c_000388
DivK1c_003750
SPECTRUM1500159
SPBio_000170
SPBio_002124
CARBAMAZEPINE [WHO-DD]
CARBAMAZEPINE [WHO-IP]
BPBio1_000225
GTPL5339
SCHEMBL19838283
HMS501D10
HMS640O02
HY-B0246R
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
WLN: T C676 BNJ BVZ
Carbamazepine (JP17/USP/INN)
CBZ;NSC 169864
N03AF01
SPD-417
Carbamazepine - Bio-X trade mark
Carbamazepine, analytical standard
NINDS_000388
Carbamazepine, 1mg/ml in Methanol
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS2095K05
HMS2233G16
HMS3039K09
HMS3259B21
HMS3260L06
HMS3372J13
HMS3657G03
HMS3712K05
HMS3747E03
Pharmakon1600-01500159
CARBAMAZEPINE [ORANGE BOOK]
BCP21380
HY-B0246
PXB90221
5-Carbomoyl-5H-dibenzo(b,f)azepine
Tox21_110104
Tox21_202273
Tox21_300195
Tox21_500292
AC2074
BDBM50003659
CCG-38931
NSC755920
s1693
STK177357
STL453548
11-benzo[b][1]benzazepinecarboxamide
5H-Dibenz[b,f]azepine-5-carboxamine
5H-Dibenzo(b,f)azepin-5-carboxamide
Carbamazepine 1.0 mg/ml in Methanol
CARBAMAZEPINUM [WHO-IP LATIN]
AKOS003235644
AKOS025397243
Tox21_110104_1
AC-9538
DB00564
KS-5146
LP00292
NC00679
NSC-755920
SDCCGSBI-0050280.P005
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
CDS1_002710
IDI1_000388
5H-Dibenzo[b,f]azepine-5-carboxamide #
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-04
NCGC00015234-05
NCGC00015234-06
NCGC00015234-07
NCGC00015234-08
NCGC00015234-09
NCGC00015234-10
NCGC00015234-12
NCGC00015234-13
NCGC00015234-14
NCGC00015234-15
NCGC00015234-16
NCGC00015234-18
NCGC00015234-19
NCGC00015234-33
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NCGC00253982-01
NCGC00259822-01
NCGC00260977-01
BC166161
SY002823
(z)-5h-dibenzo[b,f]azepine-5-carboxamide
SBI-0050280.P004
5H-dibenzo[b,f]azepine-5-carboximidic acid
DB-047659
Dibenzo[b,f]azepine-5-carboxylic acid amide
EU-0100292
NS00000207
SW220141-1
EN300-21678
BIM-0050280.0001
C 4024
C06868
Carbamazepine, meets USP testing specifications
D00252
5H-Dibenz(b,f)azepine-5-carboxamide maleic acid
5H-Dibenz(b,f)azepine-5-carboxamide oxalic acid
AB00051931-17
AB00051931-18
AB00051931_19
AB00051931_20
A820074
Q410412
carbamazepine host structure with maleic acid removed
carbamazepine host structure with oxalic acid removed
SR-01000000229-2
SR-01000000229-4
SR-01000000229-7
5H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acid
BRD-K71799949-001-06-7
BRD-K71799949-001-35-6
BRD-K71799949-001-36-4
F0348-2551
Z104508594
carbamazepine host structure with DL-tartaric acid removed
Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)
carbamazepine host structure with 4-hydroxybenzoic acid removed
Carbamazepine, British Pharmacopoeia (BP) Reference Standard
Carbamazepine, European Pharmacopoeia (EP) Reference Standard
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
206-062-7
Solubility of Benzo[b][1]benzazepine-11-carboxamide
The solubility of benzo[b][1]benzazepine-11-carboxamide, with the chemical formula C15H12N2O, can be described as follows:
It is important to note that the solubility may also vary based on concentration and specific environmental conditions. Understanding these aspects of solubility is crucial for applications and handling of benzo[b][1]benzazepine-11-carboxamide in various fields.
In conclusion, while the compound exhibits characteristics that may allow for solubility in certain environments, specific quantitative data about its solubility in various solvents is essential for practical applications.